Success stories 25 Mayo 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
News 18 Nov 2020 Lonza manufactures coronavirus vaccine for Moderna Lonza plans to start production of Moderna’s coronavirus vaccine in Switzerland before the end of the year. Moderna published the initial results...
News 11 Ago 2020 Moderna driving forward production of vaccine from Basel The Swiss government has just signed a supply contract with Moderna for 4.5 million doses of a coronavirus vaccine. The US company is now opening...
ニュース 24 Nov 2020 モデルナ社開発のコロナウイルスワクチンをスイス企業が製造へ スイスの大手製薬企業ロンザ社は、米国モデルナ社が開発した新型コロナウイルスワクチンの生産を、年内にもスイスで開始する予定です。モデルナ社の開発したワクチンは第3段階治験の暫定結果が発表され、有効性が94.5%とされています。同社はワクチン生産の強化のため、スイス・バーゼル州に子会社を...